These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2349607)

  • 1. Predicting the daily prothrombin time response to warfarin.
    Farrow L; Mungall D; Raskob G; Hull R
    Ther Drug Monit; 1990 May; 12(3):246-9. PubMed ID: 2349607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response.
    Lee C; Coleman RW; Mungall DR
    Clin Pharm; 1987 May; 6(5):406-12. PubMed ID: 3665392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation.
    Svec JM; Coleman RW; Mungall DR; Ludden TM
    Ther Drug Monit; 1985; 7(2):174-80. PubMed ID: 4024210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Bayesian regression program for predicting warfarin response.
    Boyle DA; Ludden TM; Carter BL; Becker AJ; Taylor JW
    Ther Drug Monit; 1989; 11(3):276-84. PubMed ID: 2728086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram for dosing warfarin at steady state.
    Fredriks DA; Coleman RW
    Clin Pharm; 1991 Dec; 10(12):923-7. PubMed ID: 1773579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecasting.
    Sasaki T; Tabuchi H; Higuchi S; Ieiri I
    Pharmacogenomics; 2009 Aug; 10(8):1257-66. PubMed ID: 19663670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin dosage predictions assisted by the analog computer.
    Carter BL; Barr W; Rock W; Taylor JW
    Ther Drug Monit; 1988; 10(1):69-73. PubMed ID: 3376184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin does not alter warfarin's disposition or anticoagulant effect.
    Rocci ML; Vlasses PH; Distlerath LM; Gregg MH; Wheeler SC; Zing W; Bjornsson TD
    J Clin Pharmacol; 1990 Aug; 30(8):728-32. PubMed ID: 2401751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma warfarin levels and variations in steady-state prothrombin times.
    White RH; Zhou H; Romano P; Mungall D
    Clin Pharmacol Ther; 1995 Nov; 58(5):588-93. PubMed ID: 7586953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin.
    Miller JW; Skerjanec A; Knadler MP; Ghosh A; Allerheiligen SR
    Pharm Res; 2001 Jul; 18(7):1024-8. PubMed ID: 11496940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of erythromycin in patients receiving long-term warfarin therapy.
    Weibert RT; Lorentz SM; Townsend RJ; Cook CE; Klauber MR; Jagger PI
    Clin Pharm; 1989 Mar; 8(3):210-4. PubMed ID: 2706893
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.
    Shen C; Huang X; Li J; Zhang P; Li L; Zhang W; Hu T; Pappoe F; Huang J; Tang H
    Xenobiotica; 2016; 46(6):530-41. PubMed ID: 26548565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racemic warfarin and trimethoprim-sulfamethoxazole interaction in humans.
    O'Reilly RA; Motley CH
    Ann Intern Med; 1979 Jul; 91(1):34-6. PubMed ID: 464451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats.
    Cao YG; Liu XQ; Chen YC; Hao K; Wang GJ
    Eur J Pharm Sci; 2007 Feb; 30(2):175-80. PubMed ID: 17169538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple technic for predicting daily maintenance dose of warfarin.
    Williams DB; Karl RC
    Am J Surg; 1979 Apr; 137(4):572-6. PubMed ID: 426209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient management of warfarin therapy: comparison of computer-predicted dosage adjustment to skilled professional care.
    White RH; Mungall D
    Ther Drug Monit; 1991 Jan; 13(1):46-50. PubMed ID: 2057991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of warfarin at steady state.
    Murray B; Coleman R; McWaters D; Ludden T; Mungall D
    Ther Drug Monit; 1987; 9(1):1-5. PubMed ID: 3576653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin.
    Kong AN; Tomasko L; Waldman SA; Osborne B; Deutsch PJ; Goldberg MR; Bjornsson TD
    J Clin Pharmacol; 1995 Oct; 35(10):1008-15. PubMed ID: 8568008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the relative sensitivities of factor VII and prothrombin time measurements in detecting drug interactions with warfarin.
    Pitsiu M; Parker EM; Aarons L; Holt B; Rowland M
    Eur J Clin Pharmacol; 1992; 42(6):645-9. PubMed ID: 1623906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a computer-assisted method for individualized anticoagulation: retrospective and prospective studies with a pharmacodynamic model.
    Abbrecht PH; O'Leary TJ; Behrendt DM
    Clin Pharmacol Ther; 1982 Jul; 32(1):129-36. PubMed ID: 7083727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.